Skip to content

Comparison Between Immediate and Gradual Decannulation

Feasibility and Safety of Immediate Versus Gradual Decannulation: a Randomised Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02469909
Enrollment
100
Registered
2015-06-12
Start date
2015-06-30
Completion date
2019-01-31
Last updated
2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheostomy

Keywords

Decannulation, tracheostomy

Brief summary

The investigators propose to examine the feasibility and safety of immediate (single stage) decannulation in adult patients in a controlled randomized trial. Patients who will be found fit for decannulation after an otolaryngologist and intensive care specialist assessment will be randomized into two groups: immediate decannulation and gradual decrease in cannula size. Both groups of patients will be monitored after decannulation and in the outpatient clinic for any complications following the procedure.

Detailed description

Recruitment of the patients will be demands for decannulation evaluation of different departments in our institution. All patients who will agree to participate in the study and meet the inclusion criteria would undergo three major steps 1. Pre decannulation evaluation by otolaryngologist and intensive care specialist following inclusion criteria. 2. Decannulation: In the immediate decannulation group - the tracheostomy tube is removed and the patient would be monitored overnight in an intermediate monitored unit. On the next day a clinical evaluation would be held, and the patient would be discharge or transferred to his department according to the clinical course of the patient. In the gradual decannulation group: The tracheostomy tube will be reduced in 2 sizes compared with the initial inner diameter of the tube. The patients will remain with the reduced tube for 48 hours, and the tube will be removed if the patients would meet pre-decannulation evaluation. 3. Follow up: All patients would be followed in 7, 30, 90 days following decannulation in the outpatient clinic or in their departments if still hospitalized. In these visit questionnaires regarding possible respiratory complications will be documented.

Interventions

OTHERPre-discharge evaluation

After an overnight observation, patients in the immediate decannulation group would would undergo clinical and laboratory evaluation including vital signs and blood gases.

OTHERoutpatient clinic follow ups

all patients would visit the otolaryngology outpatient clinic in 7, 30 and 90 days following decannulation for an evaluation of any respiratory complications following decannulation

PROCEDUREimmediate decannulation

the tracheostomy tube is removed at once

OTHEROvernight observation

patients in the immediate decannulation group would be admitted for an overnight in intensive care unit or the otolaryngology department. they would be monitored for any respiratory or airway complications.

PROCEDUREGradual tracheostomy tube decrease

The tracheostomy tube will be reduced in 2 sizes compared with the initial inner diameter of the tube. The patients will remain with the reduced tube for 48 hours, and the tube will be removed if the patients would meet pre-decannulation evaluation

Sponsors

Soroka University Medical Center
CollaboratorOTHER
Kaplan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients who underwent tracheostomy with the following conditions: 1. Tracheostomy tract is established more than 7 days 2. Normal vital signs: heart rate 50-100, 90\<systolic BP \<180, respiratory rate \<20. Saturation \>90% in room air 3. Effective cough 4. Normal swallows \\ feeding possibility 5. \# steps endoscopy test: through the tracheostomy tube, normal naso-laryngeal and through the tract with an upper look towards the subglottic area in order to detect subglottic stenosis. 6. Ability of the patient to breath with a capped cannula.

Exclusion criteria

* Patients with a major complication in tracheostomy procedure (subcutaneous emphysema, pneumothorax, bleeding, false root) * patient with anatomical neck abnormality * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
re-insertion of the tracheostomy tube7 daysnumber of patients who needed re-insertion of the tracheostomy tube due to respiratory distress within 7 days of decannulation
mechanical ventilation7 daysnumber of patients who needed mechanical ventilation due to respiratory distress within 7 days of decannulation

Secondary

MeasureTime frameDescription
Death from any cause90 daysnumber of patients who died from any cause within 90 days of decannulation
Respiratory distressup to 90 fays following decannulationnumber of patients who reported difficulty breathing suggestive of stridor or by examination or intervention within 90 days of decannulation
Pneumonia90 days following decannulationnumber of patients who had a diagnosis of pneumonia in the period of 90 days following decannulation

Countries

Israel

Contacts

Primary ContactOded Cohen, Dr
oded915@gmail.com+972-544682490
Backup ContactYaara Haimovich
yaaraha@clalit.org.il+972-52-8580806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026